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The  understanding of antigenic diversity in Plasmodium falciparum  is important  in 
research aimed at the development of a  vaccine against malaria. Previous studies (1- 
5)  have  demonstrated,  with  a  variety of biochemical  and  immunological  markers, 
that different geographical isolates could present distinct characteristics. None of these 
studies, however, has shown any diversity among the antigens exposed at the surface 
either of the parasite or the infected host cell, i.e., antigens that are most likely to play 
a  role in the development of a  protective immunity (6). Protective immunity against 
P. falciparum has been shown to have a  strain-specific component  (7-9). 
We have examined the antigenic diversity of determinants expressed on the surface 
of squirrel monkey erythrocytes infected with P. falciparurn using a technique of surface 
immunofluorescence.  We  found  that  three  geographical  strains  express  different 
surface  determinants  and  that  parasites  of a  given  strain  could  undergo  antigenic 
variation; and  we describe a  situation where  the transfer of a  clone of P. falciparum 
from a  splenectomized into an intact squirrel monkey results in a switch from one set 
of erythrocyte-associated antigens  to  another.  This  novel  mechanism  of antigenic 
variation  in  P. falciparum  is  discussed  in  the  context  of the strain-specific antigenic 
diversity of this parasite and protective immunity. 
Materials  and  Methods 
Parasites.  The Ugandan Palo Alto/PLF-3 strain, Gambian FCR-3 strain, and Indochina-I 
strain of P. falciparum,  which have been adapted to the squirrel monkey, Saimiri sciureus (10), 
have been used  throughout  these experiments.  Parasites were obtained by venipuncture of 
anesthetized, infected monkeys. Infected blood was cryopreserved in liquid nitrogen and thawed 
when  needed according to the  method  of Diggs et  al.  (11).  Short-term cultures of fresh or 
thawed infected erythrocytes were performed as described by Trager and Jensen  (12),  except 
that fetal bovine serum (FBS) was substituted for human serum. 
In view of the differences observed earlier between parasites maintained in intact (S+) I and 
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splenectomized  (S-)  animals  (13),  we maintained  two different  lines for each strain  by serial 
transfer either in S + or S  animals. 
Clone B-11  was  derived from  PLF-3  (S- line)  in  the following way:  an  in vitro culture of 
PLF-3 in human erythrocytes was established and grown for 5 mo in routine culture conditions 
(12); infected erythrocytes were diluted in medium to a  final concentration of 10 parasites/ml 
and normal erythrocytes were added to obtain a 2.5% hematocrit; the suspension was distributed 
into a 96-well flat-bottomed microtiter plate, at  100 ~l/well, and cultivated at 37°C in a candle- 
jar;  the medium was changed  daily and  fresh erythrocytes were added  on days  5 and  11;  on 
day  16, all cultures were screened for parasite growth using Giemsa-stained thin films. A single 
clone was isolated by this procedure and this population was subsequently re-cloned using the 
same technique. Three clones were isolated and one of these (PLF-3/B-11) was transferred into 
squirrel monkey erythrocytes in vitro and injected 2 d  later into a spleneetomized animal. 
Animals and Immune Sera.  Female Bolivian squirrel monkeys (South American Primates, Inc., 
Miami, FL) were used throughout  this study. Splenectomy was performed as described earlier 
(10)  and splenectomized animals were infected within  1 wk after splenectomy. 
Fig.  1 gives details of the evolution of parasitemia  in six monkeys  after primary  infection 
with different lines of PLF-3, the timing of recovery and challenge infections, and the follow-up 
of parasitemia after challenge with either homologous or heterologous populations. Fig. 2 shows 
the same in  five monkeys  infected with  different  lines of Indochina-1;  secondary  peaks  were 
identified as new populations (Indo B, Indo-C, Indo-D, Indo-E, Indo-F, and Indo-G). Challenge 
infections  were  performed  by  intravenous  inoculation  of a  cryopreserved  stabilate  of  the 
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FIG.  1.  Evolution ofparasitemia and timing of challenge in various monkeys infected with different 
lines of the Ugandan Palo Alto strain of P. falczparum. Arrows indicate timing of infection,  challenge 
with a specified population, or drug treatment (CQ, chloroquine, intramuscular). HOMMEL  ET  AL.  1139 
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Fzo.  2.  Evolution of infection and  timing of challenge in  various  monkeys  infected  with  the 
Indochina-I  strain  of P. falciparum. Arrows indicate the timing of infection, challenge, or drug- 
treatment  (Q,  quinine,  intravenous).  New populations  isolated  from  recrudescent  or secondary 
peaks  are  identified in  brackets.  When  a  secondary  peak  was  observed,  the maximum  level  of 
parasitemia is indicated. 
appropriate  population  thawed  as  indicated  above.  Sera  were  taken  before  infection,  after 
recovery, and  5-10  d  after each  challenge infection. Other  monkeys were used  in this study 
either for subinoculations or as a source of infected erythrocytes, but details on parasitemia are 
not given. 
Imrnunofluorescence.  The  technique  for  surface  immunofluorescence  using  fresh,  unfixed, 
infected erythrocytes had been previously used for the demonstration of variant antigens on the 
surface of P. knowlesi-infected  erythrocytes  (14). The modifications were briefly the following: 
100 #1 of each serum dilution  (1:5,  1:25,  1:125, and  1:250)  was incubated  in a  hemolysis tube 
for 30 min at 37°C with 7.5-10 p,l of packed erythrocytes. After centrifugation for 5 rain at 500 
g  (PR-6  Centrifuge;  International  Equipment  Co.,  Needham  Heights,  MA),  the  pellet  was 
washed twice in 3 ml medium and incubated  in  100/d of a  1  : 100  dilution of the IgG fraction 
of a rabbit anti-squirrel monkey IgG for 30 rain at 37°C. After two further washings, the pellet 
was incubated in 100 ~1 of a  1:25 fluorescein-labeled goat anti-rabbit IgG (Nordic Immunolog- 
ical Laboratories,  El Toro, CA)  for 30  rain at  37°C.  After two final washings,  a  drop of the 
suspension  was  examined  with  a  Leitz  Orthoplan  fluorescent  microscope  (E.  Leitz,  Inc., 
Rockleigh, N J).  Erythrocytes  infected with  late developmental stages of P. falciparum  can  be 
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light, only pigment bearing erythrocytes show  a  rim-like membrane associated  fluorescence 
when the assay is positive (Fig. 3). A reading was only considered negative if 20 trophozoite/ 
schizont-infected erythrocytes showed  no membrane fluorescence.  Similarly, the percentage of 
fluorescent trophozoite/schizont-infected erythrocytes was  determined by  examining under 
fluorescent light  the  cells  with  pigment  visible under bright  field.  Other  fluorescent cells, 
including  lymphocytes, free parasites, or lysed infected cells, are visible but were not considered 
in this study. The medium used for incubation and washing was RPMI 1640. Both the rabbit 
anti-squirrel monkey lgG and the fluorescein-labeled goat anti-rabbit IgG were adsorbed with 
normal squirrel monkey erythrocytes. 
Indirect  fluorescent antibody test  (IFAT)  using acetone-fixed antigen was  performed  as 
described by Voller and O'Neill (15), but using a double sandwich technique with the same 
antiserum and conjugate as above. 
Treatment of Erythrocytes with Enzymes.  Erythrocytes were  incubated in  1 ml  RPMI  1640 
containing  0.1 mg/ml of trypsin (Sigma Chemical Co., St. Louis, MO), 0.1 mg/ml chymotrypsin 
(Worthington Biochemial Corp., Freehold, N  J)  or 25  U  neuraminidase (Gibco Laboratories, 
Grand Island, NY)  for 30 rain at  37°C. Cells were washed three times in 3 ml RPMI  1640. 
Trypsin-treated cells were then incubated at 37°C for  15 min with soybean trypsin inhibitor 
(1  mg/ml; Millipore Corp., Bedford,  MA) and chymotrypsin-treated cells were incubated for 
15  min with  phenylmethylsulfonylfluoride (PMSF)  (Sigma Chemical  Co.,  10  -4  M).  After 
treatment with protease inhibitors, the cells were washed three times in 3 ml RPMI 1640. 
Results 
Strain-specific  Antigenic  Diversity.  In looking for strain-specific diversity of erythro- 
cyte-associated antigens, we found that  the three lines of parasites tested differed in 
the antigenic determinants as detected by surface immunofluorescence (Table I). The 
convalescent sera gave a high specificity, but a low titer of antibodies (1:5); with these 
sera, it was possible to distinguish between the three different strains. The hyperim- 
mune sera  (C-4)  gave higher titers  (1:125), but a  cross-reactivity between Palo Alto 
and FCR-3 was observed, while the Indochina-  1 strain remained antigenically  distinct. 
Only the  membranes of erythrocytes infected with  late  trophozoites or schizonts 
FIG. 3,  Surface  fluorescence  ofschizont-induced erythrocytes. Infected blood was incubated with 
immune squirrel monkey  serum followed  by rabbit anti-squirrel monkey  IgG and rhodamine-labeled 
goat anti-rabbit IgG. The same field (x 630) shows erythrocytes examined under bright field (a) 
and ultraviolet light (b). Arrows identify the cells with pigment detected in a which are fluorescent 
in b. HOMMEL  ET  AL.  1141 
TABLE  I 
Detection of Strain-specific Differences Using Surface Immunofluorescence 
Anti-PLF-3  Anti-FCR-3  Anti-Indochina- 1 
(3 ~  IS  +  )  (36/s +  )  (32/s +  ) 
R  C-4  R  C-4  R  C-4 
PLF-3 (Uganda)  1:5  1:125  0  1:125  0  0 
FCR-3 (The Gambia)  0  1:125  1:5  1:125  0  0 
Indochina- 1 (Viemam/Kampuchea)  0  0  0  0  1:5  1  : 125 
Three strains  were tested  with their respective  antisera.  For each immune monkey,  antibody  titers  are 
given for convalescent  serum (R) and serum taken after the 4th challenge (C-4) infection. 
TABLE  II 
Comparison of S + and S- Lines Using Surface Immunofluorescenee 
Anti-PLF-3/S  +  Anti-PLF-3/S 
31/S  ÷  29/S  ÷  30/S -  27/S- 
R  C-4  R  C-4  R  C-4  R  C-4 
Anti-Indochina/S  + 
32/S  +  54/S  + 
R  C-4  R 
PLF-3/S  + line  l:5  1:125  1:5  1:125  0  0  0  1:125  0  0  0 
PLF-3/S- line  0  0  0  0  1:5  1:125  1:5  1:125  0  0  0 
Indochina- 1/S  ÷ line  0  0  0  0  0  0  0  0  1:5  1:125  1:5 
Indochina- l/S- line  0  0  0  0  0  0  0  0  0  0  0 
The S  + and S- lines of PLF-3 and Indochina- 1 were compared by surface immunofluorescence,  using their 
respective  antisera.  For each immune monkey,  antibody titers  are given for convalescent  serum (R)  and 
serum taken  after the 4th challenge (C-4) infection. 
show  a  rim-like  fluorescence  (Fig.  3);  normal  erythrocytes  or  erythrocytes  infected 
with ring-stage parasites  do not show any  fluorescence. 
The  results  were  identical  with  infected  erythrocytes  present  in  the  peripheral 
bloodstream,  infected  erythrocytes  maintained  in  vitro for  24-40  h  (to  allow matu- 
ration  from the ring to  the trophozoite/schizont  stage)  or with  infected erythrocytes 
that  had  been cryopreserved  (11)  and subsequently  grown in vitro for 24 h. 
In  contrast  to  surface  immunofluorescence,  IFAT  using  acetone-fixed,  infected 
erythrocytes as antigen detects the presence of antibodies against a  variety of malarial 
antigens,  not  necessarily  localized on  the  surface  of the  cell, and  does  not  show  any 
strain  specificity.  This  assay  demonstrates  that  all  sera  have  comparable  antibody 
titers (1:80 for convalescent sera;  1:1,280-1:2,560  for hyperimmune  sera), which shows 
that  there is no difference in  the level of antibody  production  in  intact  or splenecto- 
mized animals.  Sera from animals with a  patent parasitemia were always negative by 
surface immunofluorescence,  although they had already detectable titers in the IFAT. 
This demonstrates  that  surface immunofluorescence can be used to examine eryth- 
rocyte-associated  antigens  in  P. falciparum-infected  cells  and  to  distinguish  between 
different populations. 
Modulation by the Spleen.  Table II shows that different antigens are expressed on the 
surface ofS + and S- lines, both for the PLF-3 and the Indochina-1  strains. The results 
obtained with monkey 27/S-,  infected first with the S- line and then challenged with 
the  S +  line,  show  that  a  single  challenge  with  a  different  phenotype  is  sufficient  to 
induce a  lasting immunity  to this phenotype.  This stresses  the importance of selection 1142  ERYTHROCYTE  SURFACE ANTIGENS OF PLASMODIUM FALCIPARUM 
TABLE III 
Spleen-modulated Antigenic Variation 
Successive monkeys 
28/S-  35/S  Day 8  40/S+  Day 20  42/S +  45/S  Day 14 
Anti-S-  +(90%)  +(90%)  +(90%)  +(45%)  -  -  +(80%) 
Anti-S  ....  +(40%)  +(90%)  +(90%)  +(20%) 
Follow-up of surface IFAT using  serum 30/S- and 31/S  + in five serial transfers of clone PLF-3/B-II  in 
splenectomized and intact  squirrel monkeys. Positive means a  titer  of  1/125 and  negative means no 
fluorescence at 1/5. The percentage indicates the number of pigment-containing erythrocytes that presents 
a rim-like fluorescence  under ultraviolet light. 
of S +  and  S-  lines by  serial  transfer before  attempting differential serotyping;  in 
earlier studies (13), where this was not done, results were less clear-cut. 
In the case of PLF-3, each of the S + and the S- specificities remained stable over 
successive transfers in intact or splenectomized monkeys, whereas the  S + line of the 
Indochina-1 strain underwent antigenic variation (see  below), a  feature that compli- 
cates the comparison ofS + and S- specificities in the latter strain. The S- line of PLF- 
3 was cloned in vitro and one of the clones (PLF-3/B- 11) was reintroduced into an S- 
squirrel monkey. This clone was recognized by serum 30/S-, which indicates that the 
S- specificity had remained stable over long-term in vitro cultivation. 
To demonstrate the role of the spleen in this antigenic expression, we transferred 
clone B-11  from a  splenectomized to an intact animal. Table III gives the results of 
this critical experiment. In the S + animal, the S- specificity was still found on day 8, 
and surface  antigens then  progressively switched  from  the  S-  to  the  S +  specificity 
between days  14  and  20.  In  the  reverse  experiment  (i.e.,  when clone B-11/S  +  was 
transferred from an intact to a splenectomized animal), only a partial switch from the 
S + to the S- specificity had occurred (80% parasites showed the S- specificity) by the 
time  parasitemia  reached  its  terminal  peak,  at  which  point  the  experiment  was 
interrupted. The fact  that  the  S- specificity can be found on erythrocytes of intact 
animals indicates that the antigenic difference between S + and S- lines does not relate 
to some peculiar characteristic of erythrocytes in splenectomized animals. 
Effect  of Enzyme  Treatment.  When parasites  had  developed  from  rings to  tropho- 
zoites/schizonts in culture, infected blood was  treated with  neuraminidase, chymo- 
trypsin, or trypsin and the unfixed cells were tested by IFAT. Treatment with trypsin 
or chymotrypsin completely abolished membrane-associated fluorescence. Neuramin- 
idase did not affect the results of IFAT. 
To  ensure that  this  result  was  not  an  effect  of proteolytic enzymes on  immune 
serum,  even  after  inhibition of soybean trypsin  inhibitor or  PMSF,  we  tested  the 
serum dilution that had been incubated with the enzyme-treated cells and performed 
a control IFAT with untreated cells. No difference in antibody titer could be detected, 
which  confirmed that  the  protease  treatment  altered  the  antigen rather  than  the 
antibody. 
Antigenic  Variation of the  Indochina-1 Strain.  When  we  examined the  reactivity in 
monkey 32/S + infected with Indochina-1 of surface determinants on parasitized cells 
taken at the primary peak of parasitemia (Indo-A) and at a secondary peak (Indo-B) 
obtained after challenge of this animal with Indo-A and subsequently transferred into HOMMEL ET AL.  1143 
a  new  animal  (48/S+),  these  two  populations  proved  to  be  antigenically  distinct. 
Further secondary or recrudescent peaks were isolated as shown in Fig.  2: Indo-C and 
Indo-D from monkey 47, which had been infected with Indo-A and challenged with 
Indo-C;  Indo-E, and Indo-F, and Indo-G from monkeys 53 and 48, which had both 
been infected with Indo-B. 
Table  IV shows the reactivity of different  sera taken from monkeys infected  and 
challenged  with  populations A,  B,  C,  D,  and  F  against  the seven  different  variant 
antigenic  types  (VAT)  that  have  emerged  from  Indochina-l.  These  sera  reacted 
neither with the Indochina/S- line nor the S + and the S- lines of PLF-3. These results 
show that  in all  monkeys, the serum from convalescent  animals  (R)  always reacted 
specifically with the VAT inoculated.  Later challenges with the same VAT increased 
the antibody titer to this VAT, but cross-reactions started to appear once new VAT 
had emerged.  In monkey 47,  for example,  the initial  inoculum was Indo-A and the 
convalescent  serum  was  specifically  directed  against  Indo-A,  although  at  this  time 
Indo-C had already emerged; a later serum (after challenge with Indo-C) recognized 
both A and C as well as B  (although no infection with B had been detected).  Further 
challenges with Indo-C increased the titer to C, but not to A  or B. None of the sera 
taken from monkey 47 recognized VAT D, E, or F. Similarly, serum C-9 of monkey 
32, which had been infected and challenged with A, B, C, and F, recognized all these 
VAT with different antibody titers, but did not recognize Indo-D or E  (to which the 
animal has not been exposed). In contrast, the convalescent serum (R) and the serum 
taken after the fourth challenge with Indo-A (C-4) were specific to VAT A. 
TABLE IV 
Antigenic  Variation in the Indochina-1 Strain 
Parasite population 
32/S*  47/S  +  48/S  ÷  56/S  ~  54/S  ÷  53/S  + 
R  C-4  C-9  R  C-I  C-3  R  C-3  R  C-3  R  C-2  R  C-2 
lndo-A 
Saimiri 32  1:5  1:125 
Saimiri 54  1:5  1:125 
Indo-B 
Saimirl 48  0  0 
Saimirl 53  0  O 
Indo-C 
Saimiri 47  0  0 
Indo-D 
Saimiri 56  0  0 
lndo-E 
Saimiri 53  0  0 
Indo-F 
Saimiri 48  0  0 
[ndo-G 
Saimiri 48  0  0 
1:125  1:5  1:25  1:25  0  0  0  0  1:5  1:25  0  0 
t:[25  1:5  !:25  1:25  0  0  0  0  1:5  I:25  0  0 
1:25  0  1:25  1:25  1:5  1:125  0  0  0  0  1:5  1:25 
1:25  0  1:25  1:25  1:5  1:125  ND*  ND  ND  ND  1:5  1:25 
1:25  0  1:25  1:125  0  0  0  0  0  0  0  0 
0  0  0  0  0  0  1:5  1:25  0  0  0  0 
0  0  0  0  0  0  0  0  0  0  0  0 
1:5  0  0  0  0  0  0  0  0  0  0  0 
0  0  0  0  0  0  0  0  0  0  0  0 
Populations Indo-A-G were compared  using various immune sera from animals infected and challenged with population A (32/S  + and 54/S+), 
population  B  (48/8  +  and  53/S÷),  or  population  D  (56/S *)  The  animal  47/S ~  had  been  infected  with  population  A,  had  developed  a 
recrudescence  with population C, and was further challenged  with C. Sera R, C-l, C-2, C-3, C 4, and C-9 refer  respectively to sera taken after 
recovery or after one  to  nine challenge  infections.  Serum C-4 of monkey 32/S  ~ was  taken  after  four challenge  infections with  population A, 
while serum C-9 was taken after further challenge with B, C, and F (see  Fig.  1 for details of immunization schedule)  Only four  dilutions (1:5, 
1:25,  1:125, and  1:250)  were  tested  for all sera. 
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These  results  indicate  that  the  molecules  exposed  at  the  surface  of erythrocytes 
infected with P. falciparum are capable of antigenic variation under immune pressure. 
Antigenic Variation of the Palo Alto Strain.  With this strain, spontaneous recrudescent 
peaks were not observed and secondary peaks after homologous challenge were rare. 
Antigenic variation  was observed after passive transfer of immune serum. 
An intact monkey infected with PLF-3/S ÷ was treated with  1.5 ml of anti-S ÷ serum 
(31/S+/C-4)  when parasitemia had reached 0.4%; parasitemia was totally suppressed 
48  h  later  and  remained  negative  for 9  d;  a  recrudescent  peak  (0.35%  parasitemia) 
was observed  15 d  after passive transfer and  this population  proved to be of the S- 
phenotype,  i.e.,  positive by surface  immunofluorescence with  anti-S-  serum.  In this 
intact  monkey,  PLF-3  had  switched  from the  S +  to the  S-  specificity  after  passive 
transfer of anti-S + serum.  In this intact  monkey, PLF-3 had switched from the S ÷ to 
the S- specificity after passive transfer of anti-S + serum. 
A  splenectomized monkey infected with clone B-1 l/S-  was treated  with  1.5 ml of 
anti-S+/S -  serum  (27/S-/C-6)  when  parasitemia  reached  7.2%;  24  h  later,  the 
parasitemia  had  dropped  to  1.7%,  but  progressively  increased  thereafter.  A  second 
peak (14.2% parasitemia)  was observed 10 d after passive transfer and this population 
was not recognized by any of the anti-S- or anti-S + sera tested, and was consequently 
considered to be a  new VAT of clone B-1 l/S-. This experiment shows that antigenic 
variation can occur in a cloned population. 
Discussion 
The  data  presented  in  this  paper  demonstrate  the  antigenic  complexity  of the 
surface determinants  exposed on P. falciparum-infected  erythrocytes. The evidence for 
the existence of major alterations of the surface of erythrocytes infected with malaria 
parasites  stems  from  various  experimental  approaches,  such  as  the  observation  of 
morphological changes  (16), the biochemical detection of new determinants  (17-18), 
the study of the cell surface either with lectins (19) or with antibodies  (10,  14, 20  21), 
and  the binding of infected cells  to endothelial  cells  (22).  All these studies have one 
common feature, that surface alterations occur at the trophozoite/schizont stage (i.e., 
the second half of the 48-h developmental cycle), while no alterations are detectable 
on  earlier  forms.  In  the  present  study  we  have  confirmed  and  expanded  earlier 
observations  showing  that  new  antigenic  determinants  could  he  detected  on  the 
surface of erythrocytes infected with such late developmental stages of P. falciparum by 
using  surface  immunofluorescence  with  immune  squirrel  monkey  serum.  Surface 
immunofluorescence allows a direct examination of the surface of individual  infected 
cells,  which  means  that  blood containing a  low percentage of late  stages  (as low  as 
0.05%)  can be tested  without  prior concentration  and  that  a  heterogeneous  sample, 
containing  more  than  one serotype,  can  be  identified  by the  relative  percentage  of 
fluorescent  and nonfluorescent pigment-containing cells.  It is of interest  to recall,  in 
the  context  of antigenic  diversity  of surface  antigens,  that  extensive  serotyping  of 
variant antigens in African trypanosomes only became possible when a surface IFAT 
was  introduced  to  replace  the  neutralizing  and  agglutination  tests  used  in  earlier 
studies  (23).  We  have  demonstrated  that  different  parasite  populations  could  be 
effectively serotyped with this  method.  For instance,  three geographical strains of P. 
falciparum, one  from Uganda,  one from The Gambia,  and  the other from Vietnam/ 
Kampuchea,  proved  to  have  distinct  serotypes.  The  cross-reaction  between  FCR-3 HOMMEL ET AL.  1145 
and PLF-3, which appears after homologous challenge, could suggest that, besides a 
strain-specific antigen,  the parasite  can express cross-reactive antigens  that  are  less 
immunogenic than the strain-specific ones. This, however, is in contradiction to the 
fact that different antigenic types of the same strain (whether S  + and S-, or A and B) 
do not appear to express such a cross-reactive antigen. 
Although strain diversity of malarial antigens had been suggested by earlier studies 
(1-5), the existence of an antigenic diversity of surface determinants had not before 
been unequivocally demonstrated in P. falciparum. The biochemical nature of this kind 
of surface  alteration  on  infected  erythrocytes is  not  yet  known and  its  origin  (i.e., 
parasite-made or modified host component)  remains a  subject  for speculation.  The 
fact  that  surface  immunofiuorescence  becomes  negative  after  protease  treatment 
suggests that the molecule recognized by immune serum might be a protein. 
Acquired immunity to P. falciparum  has  a  distinct  strain-specific component. For 
instance, studies in neurosyphilitic patients infected with P. falciparum for therapeutic 
purposes have  shown  that  these  patients  could be  reinfected  more than  once with 
either homologous or heterologous strains, but that a fourfold-higher parasitemia was 
observed  in  heterologous infections  (8). Comparable results  have been  obtained  in 
splenectomized  chimpanzees  (24)  and  in  owl  monkeys  (9).  If the  strain-specific 
antigenic determinants present on the surface of infected erythrocytes are a target for 
immune mechanisms, it is essential  to determine the extent of their diversity. In this 
study,  we  have  shown  that  these  determinants  were  not  only  strain  specific,  but 
capable of antigenic variation within a  given strain.  Antigenic variation is a  process 
by which an infectious organism gains a selective advantage by changing its antigenic 
profile, thus avoiding elimination by the host's immune system. In malaria, variation 
has  been  demonstrated  in  antigens  exposed  on  the  surface of P. knowlesi schizont- 
infected erythrocytes using either the schizont-infected cell agglutination (SICA) test 
(21)  or surface  immunofluoresence  (14),  but  had  not  been  unambiguously demon- 
strated in other malaria parasites. 
We have shown that antigenic variation of the determinants exposed on the surface 
of P. falciparum-infected  erythrocytes could be induced by a  variety of environmental 
pressures.  First, antigenic variation can be modulated by the presence or the absence 
of the spleen.  With two of the strains studied,  we found a  difference in  the surface 
antigens of parasitized erythrocytes in S  ÷ or S- line squirrel monkeys. The transfer of 
a  cloned population from an S- into an S  + monkey resulted in a  progressive switch 
from one type of antigen to the other and this switch was reversible. The role of the 
spleen in the modulation of antigenic determinants on P. falciparum-infected  erythro- 
cytes resembles in some ways what has been described when P. knowlesi is transferred 
from  intact  into  splenectomized  rhesus  monkeys  (25),  where  a  SICA  +  organism 
becomes SICA-. In contrast to P. knowlesi, both the S  + and the S- lines of P. falciparum 
express  surface  antigens  (which  are  serologically different),  while  only the  SICA  + 
populations of P. knowlesi seem to express such antigens. 
Second, with  the  Indochina-1  strain,  the  infection of immune monkeys with  the 
homologous VAT produced a secondary peak of different variant specificity and, on 
one occasion, a new variant was isolated from a spontaneous recurrence peak. Six new 
antigenic determinants  were  thus  isolated  so  far.  The  fact  that  variation  has  been 
observed in an uncloned population could mean that  the variant  populations have 
emerged from minor subpopulations present in the initial  inoculum and selected by 1146  ERYTHROCYTE  SURFACE ANTIGENS  OF PLASMOD1UM FALCIPARUM 
immune  pressure.  The  serial  emergence  of at  least  three  generations  of  different 
variant  populations  and  the  absence  of regression  to  the  initial  population  after 
transfer to a  naive animal suggests that there is a  large repertoire of VAT  available, 
a  feature  that  favors  other  mechanisms,  such  as  mutation/selection  or  adaptive 
phenotypic change. 
Third, with the Palo Alto strain, where spontaneous recurrent secondary peaks do 
not  usually  occur,  the  antigenic  switch  could  he  induced  by  passive  transfer  of 
immune serum. The fact that  PLF-3 of phenotype S + can switch to an S- phenotype 
in  an  S +  animal  after  exposure  to  anti-S  +  immune  serum  demonstrates  that  the 
presence of antibodies alone can represent a  selective pressure similar to the presence 
or absence of the spleen in the modulation of antigenic expression. This confirms that 
spleen-modulation  is  essentially  a  mode  of antigenic  variation.  The  difference  in 
cytoadherence properties observed between S + and S-,  2 might be the stimulus rather 
than the consequence of spleen-modulated variation. The antigenic variation of clone 
B-1 l/S-  in an  S- monkey, after passive transfer of immune serum, shows  that  Palo 
Alto has a  wider variation  potential  than  the  S+/S -  switch  and  that  variation can 
occur in a  cloned population. It is not clear why there should be a  difference in the 
mechanisms  of antigenic  variation  between  Palo  Alto  and  Indochina-1,  but  it  is 
possible that  the  multiple drug  resistance of the  latter strain  might  give it  a  more 
plastic genetic make-up. 
The existence of antigenic variation raises the issue of how  to define strains of P. 
falciparum.  The  existing  methods  are  inadequate  and  will  need  to  be  reconsidered, 
taking into account a  number of taxonomic parameters, such as geographical origin, 
drug resistance, isoenzyme type, and serotype. 
The antibody response to different populations presents some informative features. 
The  fact  that  convalescent  sera  are  highly  specific  to  the  inoculum  could  have 
important  practical  applications.  For  instance,  if we  suppose  that  many  different 
serotypes exist in a  given geographical area, sera taken  from patients after their first 
infection  with  malaria should  have  a  special  affinity for  that  particular  strain.  In 
certain instances, we have already been able to confirm this notion in clinical malaria, 
where the serum taken from a  patient after recovery specifically recognized the strain 
isolated  from  this  patient  a  few  weeks  earlier  (M.  Hommel,  unpubished  material). 
The fact that a  monkey exposed to a  variety of different VAT still does not recognize 
all VAT  of that particular strain suggests that  the notion of a  "chronic serum" that 
would recognize all existing VAT, such as has been described in the case ofP. knowlesi 
(26), might not apply to P. falciparum infections in squirrel monkeys. It is conceivable, 
however, that the situation might be different in a more susceptible host (e.g., man or 
,'lotus),  where the parasite could move quickly from one VAT  to another  and where 
the host  would  thus  rapidly become  immune  to a  wide range  of VAT.  This would 
explain why antigenic variation had never been recognized before in P. falciparum. 
The presence of strain-specific antigenic determinants on the surface of P. falciparum- 
infected  erythrocytes  that  induce  the  production  of specific antibodies  in  immune 
individuals is a  feature  that  will have  to be examined in epidemiological studies in 
man, particularly in view of the potential role of these antigens in acquired immunity. 
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Antigenic variation and/or strain-specific diversity might explain the long time-span 
that individuals living in hyperendemic malarious areas require to become immune 
(27).  For  instance,  successive  waves  of parasitemia  could  be  explained  either  by 
superimposed  infection  with  a  different  strain  or  by the  recurrence  of a  previous 
infection after antigenic variation. The observation that the reinfection of an immune 
animal with the homologous strain can produce a  parasitemia with an antigenically 
different population is of particular importance in this context. 
Summary 
The surface of erythrocytes infected with late developmental stages of Plasmodium 
falciparum  is profoundly altered and new antigenic determinants can be detected by 
surface immunofluorescence using immune squirrel monkey serum. The expression of 
these parasite-specific antigenic determinants on the surface of the host erythrocyte 
can be modulated by the presence or absence of the spleen and by immune pressure. 
An antigenic switch occurred when a cloned population of the Ugandan Palo Alto 
strain  of P. falciparum  was transferred  from a  splenectomized into an intact monkey 
and this switch was reversible.  In another strain  (Indochina-1), we showed that  the 
parasites  isolated  during secondary and  recrudescent  peaks  expressed  erythrocyte- 
associated surface antigens different  from the parasites  isolated during the primary 
infection;  six  variant  antigenic  types  distinct  from  the  original  population  were 
isolated in this way. 
The passive transfer of immune serum can induce antigenic variation and this can 
occur in a cloned parasite. 
The various mechanisms of antigenic variation in P. falciparum  are discussed in the 
context  of strain-specific  diversity  and  the  role  of antigenic  diversity  in  acquired 
immunity. 
We wish to thank Professor J. R. David for continuous  encouragement  and helpful discussions 
at every stage of this study. 
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